Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Common Equity (2010 - 2026)

Omeros (OMER) posted Common Equity of -$63.3 million for Q1 2026, up 47.76% sequentially from -$121.2 million in Q4 2025, and up 70.34% YoY from -$37.2 million in Q1 2025.

Analysis

Omeros (OMER) Common Equity (2010 - 2026) Analysis & Trends

Omeros has reported Common Equity for 17 years, with the latest figure at -$63.3 million in Q1 2026.

  • Quarterly Common Equity rose 70.34% year-over-year to -$63.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.3 million (up 70.34% YoY) and the FY2025 annual result came in at -$121.2 million, up 33.61% from the prior year.
  • Common Equity improved to -$63.3 million in Q1 2026 per OMER's latest filing, from -$121.2 million in the prior quarter.
  • Over five years, Common Equity peaked at $85.7 million in Q4 2022 and troughed at -$228.7 million in Q2 2025.
  • A 5-year average of -$78.9 million and a median of -$63.3 million in 2026 frame the typical range for Common Equity.
  • The sharpest annual moves came in 2023 and 2024: Common Equity soared 1215.45% in 2023, then sank 1005.02% in 2024.
  • Over 5 years, Common Equity stood at $85.7 million in 2022, then plunged by 129.16% to -$25.0 million in 2023, then sank by 630.93% to -$182.6 million in 2024, then soared by 33.61% to -$121.2 million in 2025, then soared by 47.76% to -$63.3 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered -$63.3 million, -$121.2 million, and -$220.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn -51.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.35 Mn
Mar 31, 2026 -63.33 Mn
Dec 31, 2025 -121.23 Mn
Sep 30, 2025 -220.48 Mn
Jun 30, 2025 -228.69 Mn
Mar 31, 2025 -213.55 Mn
Dec 31, 2024 -182.61 Mn
Sep 30, 2024 -154.17 Mn
Jun 30, 2024 -124.60 Mn
Mar 31, 2024 -71.33 Mn
Dec 31, 2023 -24.98 Mn
Sep 30, 2023 -13.95 Mn
Jun 30, 2023 20.51 Mn
Mar 31, 2023 54.94 Mn
Dec 31, 2022 85.68 Mn
Sep 30, 2022 -46.31 Mn
Jun 30, 2022 -32.70 Mn
Mar 31, 2022 -4.93 Mn
Dec 31, 2021 23.78 Mn
Sep 30, 2021 -262.70 Mn